Main Page
Deanship
The Dean
Dean's Word
Curriculum Vitae
Contact the Dean
Vision and Mission
Organizational Structure
Vice- Deanship
Vice- Dean
KAU Graduate Studies
Research Services & Courses
Research Services Unit
Important Research for Society
Deanship's Services
FAQs
Research
Staff Directory
Files
Favorite Websites
Deanship Access Map
Graduate Studies Awards
Deanship's Staff
Staff Directory
Files
Researches
Contact us
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Deanship of Graduate Studies
Document Details
Document Type
:
Thesis
Document Title
:
EVALUATION OF TP53 MUTATIONS AMONG HEMATOLOGICAL MALIGNANCIES PATIENTS IN JEDDAH, SAUDI ARABIA
تقيم طفرات البروتين 53 في مرضى الأورام الدموية الخبيثة بجدة، المملكة العربية السعودية
Subject
:
Faculty of Applied Medical Sciences
Document Language
:
Arabic
Abstract
:
Tumor protein 53 is the most frequently mutated gene in human cancer. TP53 gene is located on the short arm of chromosome 17 and encodes for TP53 protein, which plays a significant role in many cellular processes such as apoptosis, cell cycle arrest, genomic stability, and DNA repair. In hematological malignancies, the prevalence of TP53 mutations is low compared to other tumors but associated with a complex karyotype, poor prognosis and poor response to chemotherapy. Due to the lack of data in the prevalence and prognostic value of TP53 mutations among hematological malignancies in Saudi patients, we aimed in this study to evaluate the frequency and prognostic significance of TP53 mutations in different hematological malignancies in Jeddah, Saudi Arabia. Method: 10 samples from different hematological malignancies were tested for TP53 mutations using a next-generation platform. Results: 1 out of 10 samples had a heterozygous mutation at codon 175 (exon 5) of the TP53 gene which replaces histidine with arginine (H175R). Also, there were 90 other mutations detected on 13 genes that were sequenced beside TP53. None of the other genes mutations had shown any clinical impact or association with TP53 except for two mutations in two different genes; ASXL1 (K1368T) and SETBP1 (V231L). The TP53 and ASXL1 mutations are novel variants which not reported before neither on association with case phenotype (MDS patient and associated with a complex karyotype) nor other hematological or oncology associated diseases. Conclusion: Despite the small size of this study, the identified mutations considered as variants with unknown significance and need further validation and investigation on a larger cohort to identify the pathogenicity of theses abnormality. This study recommends further investigation of genomic mutations, utilizing high throughput technologies, associated with hematological malignancies in Saudi populations
Supervisor
:
Dr. Heba Alkhatabi
Thesis Type
:
Master Thesis
Publishing Year
:
1442 AH
2020 AD
Added Date
:
Sunday, August 23, 2020
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
عبدالرحمن مهدي الامير
Al-Ameer, Abdulrahman Mahdi
Researcher
Master
Files
File Name
Type
Description
46676.pdf
pdf
Back To Researches Page